AHDC1

Across TCGA pan-cancer cohorts, AHDC1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated AHDC1 data layer compared with 22 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher AHDC1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated AHDC1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and COAD show a favorable association.

HNSC, SKCM, and PRAD are the cancer types where AHDC1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.546	0.755	.011	15	view →
SKCM	DFS	Median	All	0.816	0.592	.013	13	view →
PRAD	DFS	Median	All	0.617	0.886	.035	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
COAD	OS	Median	II,III,IV	1.000	0.773	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

AHDC1–HNSC (OS)

Open the HNSC breakdown →